
浏览全部资源
扫码关注微信
1.400038 重庆,陆军军医大学(第三军医大学)基础医学院医学遗传学教研室
2.400037 重庆,陆军军医大学(第三军医大学)第二附属医院妇产科
[郭洪,E-mail: guohong02@gmail.comGUO Hong, E-mail: guohong02@gmail.com
收稿:2022-09-30,
修回:2022-11-09,
纸质出版:2023-04-30
移动端阅览
李百青, 朱芯潼, 郭洪.
Baiqing LI, Xintong ZHU, Hong GUO. A novel mutation in
李百青, 朱芯潼, 郭洪.
Baiqing LI, Xintong ZHU, Hong GUO. A novel mutation in
目的
2
对2021年1月陆军军医大学第二附属医院接诊的1例Schmid型干骺端软骨发育不全(Schmid type metaphyseal chondrodysplasia
SMCD)家系进行疾病表型与基因型分析,结合文献复习探讨其防治手段。
方法
2
对先证者进行家系调查及系谱分析,收集先证者及家系成员的临床资料,采用全外显子组测序明确突变基因,并通过Sanger测序验证和家系共分离分析,同时结合ACMG指南进行生物信息学分析来评价变异的致病性。
结果
2
在家系患者中发现
COL10A1
基因存在新的杂合错义突变c.1843T
>
G(p.Tyr615Asp),该位点所在区域在不同物种之间高度保守,此突变可能通过影响X型胶原(α1)蛋白的三聚化及其与细胞外基质分子结合导致疾病发生。
结论
2
发现了1种SMCD的新突变,丰富了SMCD患者的突变谱,为SMCD的预防、诊断及治疗提供理论依据。
Objective
2
Schmid type metaphyseal chondrodysplasia (SMCD) is an autosomal dominant chondrodysplasia characterized by abnormal gait and skeletal deformity of limbs. In the study
we analyzed the phenotype and genotype of SMCD in a family who were admitted the Second Affiliated Hospital of our university in January 2021
and then discussed its prevention and treatment based on literature review.
Methods
2
We collected the clinical data of the patient and his family members. Then whole exome sequencing and sanger sequencing were used to identify the gene mutation. Bioinformatics analysis was performed in combination with American College of Medical Genetics (ACMG) guidelines to evaluate the pathogenicity of the variants.
Results
2
We discovered a novel heterozygous missense mutation c.1843T
>
G (p.Tyr615Asp) in
COL10A1
gene
which was highly conserved among different species. This mutation might affect the trimerization of type X collagen (α1) protein and its binding to extracellular matrix mo
lecules
and then cause the disease.
Conclusion
2
We identify a novel
COL10A1
mutation
which not only enriches the mutation spectrum of SMCD in Chinese population
but also provides theoretical basis for its prevention
diagnosis and treatment.
MÄKITIE O, SUSIC M, COLE W G. Early-onset metaphyseal chondrodysplasia type Schmid associated with a COL10A1 frame-shift mutation and impaired trimerization of wild-type α1(X) protein chains[J]. J Orthop Res, 2010, 28(11): 1497-1501. DOI: 10.1002/jor.21161.
GOYAL M, GUPTA A, CHOUDHARY A, et al . Schmid type metaphyseal chondrodysplasia with a novel COL10A1 mutation[J ] . Indian J Pediatr, 2019, 86(2): 183-185. DOI: 10.1007/s12098-018-2791-0.
ZHU Y, LI L, ZHOU L, et al . A novel mutation leading to elongation of the deduced α1(X) chain results in Metaphyseal Chondrodysplasia type Schmid[J ] . Clin Chim Acta, 2011, 412(13/14): 1266-1269. DOI: 10.1016/j.cca.2011.03.026.
CHEN Q, WU S N, CHEN Y X, et al . A novel missense COL10A1 mutation: c. 2020G > A; p. Gly674Arg linked with the bowed legs stature in the Schmid metaphyseal chondrodysplasia-affected Chinese lineage[J ] . Bone Rep, 2020, 12: 100240. DOI: 10.1016/j.bonr.2019.100240.
AIN N U, MAKITIE O, NAZ S. Autosomal recessive chondrodysplasia with severe short stature caused by a biallelic COL10A1 variant[J ] . J Med Genet, 2018, 55(6): 403-407. DOI: 10.1136/jmedgenet-2017-104885.
AL KAISSI A, GHACHEM M B, NABIL N M, et al . Schmid's type of metaphyseal chondrodysplasia: diagnosis and management[J ] . Orthop Surg, 2018, 10(3): 241-246. DOI: 10.1111/os.12382.
BATEMAN J F, WILSON R, FREDDI S, et al . Mutations of COL10A1 in Schmid metaphyseal chondrodysplasia[J ] . Hum Mutat, 2005,25(6): 525-534. DOI: 10.1002/humu.20183.
HIGUCHI S, TAKAGI M, SHIMOMURA S, et al . A Japanese familial case of Schmid metaphyseal chondrodysplasia with a novel mutation in COL10A1[J ] . Clin Pediatr Endocrinol, 2016, 25(3): 107-110. DOI: 10.1297/cpe.25.107.
WU H, WANG S, LI G, et al . Characterization of a novel COL10A1 variant associated with Schmid-type metaphyseal chondrodysplasia and a literature review[J ] . Mol Genet Genomic Med, 2021, 9(5): e1668. DOI: 10.1002/mgg3.1668.
KONG L, SHI L, WANG W, et al . Identification of two novel COL10A1 heterozygous mutations in two Chinese pedigrees with Schmid-type metaphyseal chondrodysplasia[J ] . BMC Med Genet, 2019, 20(1): 200. DOI: 10.1186/s12881-019-0937-1.
BOOT-HANDFORD R P. Gene cloning to clinical trials-the trials and tribulations of a life with collagen[J]. Int J Exp Pathol, 2019, 100(1): 4-11. DOI: 10.1111/iep.12311.
KUDELKO M, CHAN C W L, SHARMA R, et al . Label-free quantitative proteomics reveals survival mechanisms developed by hypertrophic chondrocytes under ER stress[J ] . J Proteome Res, 2016, 15(1): 86-99. DOI: 10.1021/acs.jproteome.5b00537.
PAXMAN R, PLATE L, BLACKWOOD E A, et al . Pharmacologic ATF6 activating compounds are metabolically activated to selectively modify endoplasmic reticulum proteins[J ] . Elife, 2018, 7: e37168. DOI:10.7554/elife.37168.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621